BSc Biological Sciences (First Class, University of East Anglia); PhD (University of Hull)
I am Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. I have held Research Scientist positions at Leicester University and Delta Biotechnology. I joined the Nuffield Department of Medicine at the University of Oxford in 1994 and became part of the Jenner Institute upon its foundation in 2005. Having come to Oxford as a Senior Molecular Biologist, I was appointed University Research Lecturer in 1999, Reader in Vaccinology in 2004, Jenner Investigator in 2006, and Professor of Vaccinology in 2010. You can learn more about my academic and professional background from my Wikipedia page.
I research and develop novel influenza vaccines, being responsible for a human challenge study demonstrating vaccine efficacy via T cell responses to conserved internal antigens of influenza. My focus is on viral-vectored vaccines that work by inducing strong and protective T and B cell responses.
In January 2020 I initiated production of ChAdOx1 nCoV-19. This Oxford–AstraZeneca vaccine has been used in more than 180 countries and is thought to have saved more than six million lives.
Featured story: Sarah Gilbert receives Freedom of the City of London
Sarah Gilbert receives Freedom of the City of London
In recognition of her outstanding contribution to public health and science in her role as the Oxford Project Leader spearheading the development on the Oxford–AstraZeneca COVID-19 vaccine, Professor Dame Sarah Gilbert has been awarded the Freedom of the City of London.
Two Christ Church Senior Associate Research Fellows elected Fellows of the Academy of Medical Sciences
The Academy of Medical Sciences has elected eleven University of Oxford biomedical and health scientists to its fellowship, among them are two Christ Church Senior Associate Research Fellows, Professor Sarah Gilbert and Professor Graham Ogg.